GlobeNewswire Inc.··Rosen Law FirmNektar Therapeutics Faces Securities Class Action Over Trial Enrollment Claims
Rosen Law Firm urges $NKTR investors to join class action lawsuit alleging false statements about REZOLVE-AA trial enrollment protocols caused significant shareholder losses.
NKTRsecurities class actionlead plaintiff deadline